1978
DOI: 10.1002/1097-0142(197803)41:3<880::aid-cncr2820410315>3.0.co;2-j
|View full text |Cite
|
Sign up to set email alerts
|

Lymph node involvement in carcinoma of the head of the pancreas area

Abstract: A prospective study to determine the lymph node involvement in 33 pancreatectomy specimens (regional pancreatectomy 18, total pancreatectomy 7, Whipple partial pancreatectomy 8) was undertaken. There were 22 patients with pancreas duct adenocarcinoma, 6 with ampullary carcinoma, 3 with duodenal adenocarcinoma, 1 bile duct carcinoma and 1 of undetermined site of origin. Peripancreatic lymph nodes were divided into 5 main groups with subgroups. They are 1) Superior, Superior Head, Superior Body and Gastric; 2) I… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
65
1
14

Year Published

1991
1991
2013
2013

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 254 publications
(82 citation statements)
references
References 7 publications
2
65
1
14
Order By: Relevance
“…In addition, we think that the immunoreactive peptides which are synthesised by carcinoma cells may not be present in the form of zymogen granules, unlike the trypsinogen in pancreatic acinar cells. Since it has been noted that zymogen granules are not present in any duct cell-type adenocarcinomas (Cubilla & Fitzgerald, 1978), pancreatic trypsinogen in malignant cells may not be processed in the normal way.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, we think that the immunoreactive peptides which are synthesised by carcinoma cells may not be present in the form of zymogen granules, unlike the trypsinogen in pancreatic acinar cells. Since it has been noted that zymogen granules are not present in any duct cell-type adenocarcinomas (Cubilla & Fitzgerald, 1978), pancreatic trypsinogen in malignant cells may not be processed in the normal way.…”
Section: Discussionmentioning
confidence: 99%
“…Im Gegensatz dazu kann jedoch diese Technik zu einer verla È ngerten Magenentleerungszeit und damit einem la È ngeren Krankenhausaufenthalt bei diesen Patienten fu È hren. Noch wichtiger jedoch ist, daû in verschiedenen Publikationen angezweifelt wird, ob die PPPD, bei bo È sartigen Erkrankungen angewandt, ausreichend radikal insbesondere im Bereich des erhaltenen Duodenums sei [3,5,7,8,16,18].…”
unclassified
“…hinteren pancreatikoduodenalen Lymphknoten [2,3,5,9,14]. So zeigte sich in einer Studie, dab bei periampull/iren Karzinomen im Stadium pT~ unabh/ingig vom Differenzierungsgrad und der genauen Lokalisation des Karzinoms von 15 u~,tersuchten Lymphknotengruppen nut eine befallen war, das entspricht 6,7% [2,3]. Damit liegt das Risiko der prognostisch relevanten Metastasierung in der Gr6genordnung der Letalit/it der radikaleren partiellen Duodenopankreatektomie.…”
Section: Patienten Und Methodeunclassified